Sentence examples for between main study and from inspiring English sources

The direct implication of these methodological limitations is to challenge the interpretation of these validation studies given the lack of relationship between main study and validation participants.

'I suppose adequate resourcing in advance is the key, and being realistic about time frames for getting such a thing set up..... Planning always takes longer than you expect, so I think, yes, enough anticipation of the time requirements and the resources needed is probably the key.' (016, TM) To enable integration there needed to be compatibility between the main study and the nested one.

Frequency comparisons between participants in the main study and initial non-responders provided more evidence of interest-bias: 41.7% of the former with headache in the last year, but only 24.7% of the latter, reported headache as a weekly or more frequent occurrence.

Exclusion criteria were training on an alternative AAI device between randomization for the Main Study and the one-year visit, and significant psychological distress at the one-year scenario.

More than one-third of student responses were linked to DomFreq and DomSelect alternative conceptions in both the pilot and the main study, and between 20 and 30% of possible responses were linked to DomInc and HeteroSelect.

The differences in Tmax between FF (800 μg) in the main study and FF (4000 μg) in the supportive FF TQT study were not unexpected given the different formulations and inhalers used in the two studies.

One group of participants did not give the letter any thought in the period between the main study interview and receiving the letter, or impassively described their expectations.

There also was no significant difference between the main study group and CGMS subgroup with respect to changes in A1C level during the trial (Table 1).

The main difference between the primary study and the follow-up study is that the primary study used medical record abstraction and adjudication to confirm claims-identified cases of acute pancreatitis.

Change from baseline in the 10 mg dapagliflozin groups ranged between −0.39% and −0.96% (main study end), and differences to placebo between −0.29% and −0.69%.

Comparisons were made between the two main study groups (controls and cases) and the three subgroups (controls, acyanotic group and cyanotic group).